The Value of the Turkish Translation of the Four-Dimensional Symptom Questionnaire for Turkish-sp… (NCT07653022) | Clinical Trial Compass
By InvitationNot Applicable
The Value of the Turkish Translation of the Four-Dimensional Symptom Questionnaire for Turkish-speaking Patients With Psychological Complaints and Language Barriers.
Belgium80 participantsStarted 2025-10-01
Plain-language summary
Our objectives are to determine whether the 4DSQ is valuable for Turkish-speaking patients living in Belgium who face language barriers-meaning they are not fluent in Dutch or French-and have psychological complaints, and to provide better support within the primary healthcare system for general practitioners (GPs).
We will use individual semi-structured interviews with GPs who applied the Turkish 4DSQ to diagnose only Turkish-speaking patients with mental health issues.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* We will include GPs who don't speak Turkish.
Patients must:
* be 18 years or older
* be fluent in Turkish, not in Dutch or French
Exclusion Criteria:
* Patients with severe psychiatric disorders requiring specialized care
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems to be focused on evaluating a Turkish-language questionnaire tool for doctors — does that mean my role would mainly be completing a symptom questionnaire, and if so, how would that actually affect my own care or treatment decisions?
2Since this trial is measuring whether the 4DSQ questionnaire helps doctors diagnose more accurately and change how they manage patients, could using this questionnaire during my appointments lead to any changes in how my depression or anxiety is treated — and is that a good or risky thing at this stage?
3The trial is enrolling by invitation only — can you explain why I was selected or considered for this, and what it means that it's not open to everyone?
4Since this study is in a 'not applicable' phase and seems to be a tool-validation study rather than a drug or therapy trial, does participating carry any meaningful risks, or is it essentially just answering questions about my symptoms?
5Would my symptoms of depression or anxiety be treated any differently if I participate in this study compared to just receiving standard care, and is there a reason to consider standard treatment on its own first?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of general practitioners reporting improved diagnostic accuracy following use of the 4DSQ
Timeframe: After completion of 4DSQ use in at least two Turkish-speaking patients, up to 3 months after enrolment
2
Number of general practitioners reporting changes in clinical management following use of the 4DSQ
Timeframe: After completion of 4DSQ use in at least two Turkish-speaking patients, up to 3 months after enrolment